June 7, 2023-June 8, 2023 Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development Panel within a virtual workshop presented by The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.
April 27, 2023 View Now | Clinical Outcome Assessments: Does one size fit all? Join C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform and its Rare Disease Clinical Outcome Assessment
April 27, 2023 Clinical Outcome Assessments: Does one size fit all? This webinar is presented jointly by the Rare Disease COA Consortium and C-Path’s Rare Disease Cures Accelerator-Data and...
April 26, 2023 C-Path Europe: A Global Vision of Success TUCSON, Ariz. and AMSTERDAM, April 26, 2023 — As an organization that generates regulatory-endorsed solutions and methodologies
April 25, 2023 Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts Evaluating the clinical benefit of interventions aimed at treating conditions with heterogeneous symptom....
April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
March 15, 2023 View Now | CP-RND: An Introduction to the Patient Community Hosted by the C-Path team, you can view this recorded webinar to learn more about the Critical Path for Rare Neurodegenerative Dis
November 15, 2022-November 17, 2022 Selecting Outcomes That Are Truly Meaningful to Patients Panel discussion at the National Organization of Rare Disorders (NORD) Breakthrough Summit in Washington, DC, held October 15 –
April 13, 2022-April 14, 2022 13th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 13–14, 2022 On April 13–14, 2022, the 13th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual for
June 27, 2021-July 1, 2021 The Rare Disease Clinical Outcome Assessment Consortium: Collaboration Aimed at Accelerating Rare Disease Drug Development Presented at the DIA Virtual Global Annual Meeting, held June 27 – July 1, 2021.
